Quick Answer
GLOBUS MEDICAL INC reported R&D Expense of $147.25 million for fiscal year 2025.
GLOBUS MEDICAL INC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $147.25M | -10.1% |
| 2024 | $163.75M | +32.0% |
| 2023 | $124.01M | +69.8% |
| 2022 | $73.02M | -25.0% |
| 2021 | $97.35M | +15.2% |
| 2020 | $84.52M | +40.7% |
| 2019 | $60.07M | +8.2% |
| 2018 | $55.50M | +27.1% |
| 2017 | $43.68M | -1.9% |
| 2016 | $44.53M | +22.6% |
| 2015 | $36.31M | +16.5% |
| 2014 | $31.17M | +16.0% |
| 2013 | $26.87M | -3.8% |
| 2012 | $27.93M | +19.0% |
| 2011 | $23.46M | +10.1% |
| 2010 | $21.31M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $38.07M | +7.6% | -4.7% |
| June 30, 2025 | $39.95M | +6.0% | +20.8% |
| March 31, 2025 | $33.06M | -42.3% | -6.6% |
| September 30, 2024 | $35.38M | +20.6% | -6.1% |
| June 30, 2024 | $37.70M | +76.6% | -34.2% |
| March 31, 2024 | $57.27M | +171.6% | +95.3% |
| September 30, 2023 | $29.33M | +56.8% | +37.4% |
| June 30, 2023 | $21.35M | +22.7% | +1.3% |
- GLOBUS MEDICAL INC showed a decrease of -10.1% in R&D Expense compared to the prior fiscal year.
- Over the 2010–2025 period, GLOBUS MEDICAL INC’s r&d expense has grown by 591.0% (from $21.31 million to $147.25 million).
- The most recent figure is from GLOBUS MEDICAL INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: